Evidence map›Paper›PMID 37000173›Full record

ArticleClinical and experimental dental research2023

Novel use of riboflavin as a fluorescent tracer in the dissemination of aerosol and splatter in an open operatory dental clinic.

Morgan A Emery, Donald Reed, Barbara McCracken

Abstract read
In one paragraph

Article in Clinical and experimental dental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Morgan A EmeryDepartment of Clinical Dentistry, Southern Illinois University School of Dental Medicine, Alton, Illinois, USA.ORCID 0000-0002-8886-9004
Donald ReedDepartment of Growth, Development, and Structure, Southern Illinois University School of Dental Medicine, Alton, Illinois, USA.
Barbara McCrackenDepartment of Growth, Development, and Structure, Southern Illinois University School of Dental Medicine, Alton, Illinois, USA.ORCID 0000-0002-9122-2551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe rapid spread of severe acute respiratory syndrome coronavirus 2 and the ensuing rise of the COVID-19 pandemic have impacted healthcare unprecedentedly. With the scarcity of available resources, including healthcare providers themselves, novel methods for tracking aerosol and splatter in real time are required to alleviate demand and increase safety. This study evaluates the utility of riboflavin (vitamin B MATERIAL AND

methodsIn two experimental designs, ultrasonic scaling was performed on 18 volunteers or simulated on a manikin. Riboflavin was introduced into the irrigation system, and aerosol and splatter dissemination were evaluated for both experimental designs.

resultsUltrasonic scaling utilizing riboflavin solution, in volunteers and manikins, leads to observable particle fluorescence under UV light. Contamination distribution varied across the different suction methods and between the volunteer and manikin trials. Nearly all observed incidences of contamination occurred within the operatory in use.

conclusionsRiboflavin can be used with minimal risk during dental procedures and allows for the detection of droplet spread in clinical settings in real time.

Indexed as

COVID-19Coloring AgentsDental ClinicsHumansPandemicsRespiratory Aerosols and DropletsColoring AgentsCOVID-19dentalinfection controlriboflavin

Identifiers

PMID37000173
PMCPMC10280617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.